Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 1

Status

Active not recruiting 3Recruiting 2Unknown 1Completed 1

Sponsor Class

NIH 4OTHER 2INDUSTRY 1

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Gynecologic 5

Conditions

Uterine Cervical Neoplasms 22Uterine Cervical Dysplasia 15Papillomavirus Infections 7Precancerous Conditions 5Neoplasms 4Squamous Intraepithelial Lesions 2Genital Diseases 2Atypical Squamous Cells of the Cervix 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Sexually Transmitted Diseases, Viral 1Sexually Transmitted Diseases 1Papilloma 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1HIV Infections 1Genital Neoplasms, Female 1Genital Diseases, Female 1Female Urogenital Diseases and Pregnancy Complications 1Cervical Intraepithelial Neoplasia Grade 2/3 1Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) 1Adenocarcinoma in Situ 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 36Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 29Papillomavirus Vaccines 22Vaccines 11Human Papillomavirus Recombinant Vaccine nonavalent 11Radiotherapy, Intensity-Modulated 7Human Papillomavirus DNA Tests 7Colposcopy 7Cisplatin 7Educational Status 6Carboplatin 6Blood Specimen Collection 6Vaccines, Synthetic 5Specimen Handling 5Early Intervention, Educational 5Vaginal Smears 4Methods 4Engerix-B 4fludarabine 3epigallocatechin gallate 3artesunic acid 3artemisinin 3Watchful Waiting 3Surveys and Questionnaires 3Patient Navigation 3Paclitaxel 3Imiquimod 3Hepatitis A Vaccines 3Cyclophosphamide 3halofantrine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Papillomavirus Infections × Colposcopy × Clear all
NCT06498661 2026-05-13

SHIP-A-S01

National Cancer Institute (NCI)

Phase NA Active not recruiting
750 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611540 2026-05-13

LMI-001-A-S03

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2026-05-13

LMI-001-A-S02

National Cancer Institute (NCI)

Phase NA Active not recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281430 2026-05-13

LMI-001-A-S04

National Cancer Institute (NCI)

Phase NA Recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT07281599 2026-02-02

EQUIP

Qurasense

Phase NA Recruiting
450 enrolled
Gynecologic

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT04794660 2024-03-13

CESTA

International Agency for Research on Cancer

Phase 3 Unknown
1,500 enrolled

Papillomavirus Infections

NCT04369339 2020-04-30

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

Bezmialem Vakif University

Phase NA Completed
185 enrolled

Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡